Overview
German insurer Talanx AG saw its shares decline by more than 3% on Wednesday after Meiji Yasuda Life Insurance announced a secondary placement of approximately 4.3 million Talanx shares, representing about 1.7 % of the company’s issued share capital. The shares were priced at €110.70 each, roughly a 4.5 % discount to the closing price on Tuesday evening, valuing the transaction at around €475 million.
Analyst Commentary
Morgan Stanley maintains an overweight rating on Talanx with a price target of €135 and lists the stock as a “Top Pick” in European insurance. The broker highlighted that limited liquidity has been a key concern and that the additional 1.7 % supply from the placement should improve market liquidity. Morgan Stanley also noted that Talanx currently trades at about 10 times its projected 2027 earnings (or roughly 9.5 times underlying earnings after stripping out Hannover Re), a discount to peer multi‑line insurers that trade near 12.5 times earnings.
Historical Stake Context
At the time of Talanx’s IPO, Meiji Yasuda owned 6.5 % of the insurer, linked to their partnership in the Polish insurer Warta. The Japanese insurer’s ownership fell below the 5 % threshold in 2015, and earlier this year Talanx completed the acquisition of Meiji Yasuda’s stake in Warta, formally ending the partnership between the two companies.